Agilent Technologies and the National University of Ireland (NUI) have announced the opening of a Biological Mass Spectrometry Facility on the NUI's Galway campus.
The facility is fully equipped with the latest accurate-mass quadrupole time-of-flight (Q-TOF) and triple quadrupole (QQQ) mass spectrometer platforms from Agilent.
The facility primarily focuses on functional genomics, proteomics, lipidomics and metabolomics research.
As part of the collaboration, NUI Galway will provide application notes and data for key applications using the Agilent Q-TOF and QQQ platforms.
The facility will also be used to showcase new instruments to Agilent customers and to run samples for demonstration purposes.
Primary investigators Dr David Finn, Dr Niclas Karlsson and Brendan Harhen will run the mass spectrometers at the facility.
The collaboration between NUI Galway and Agilent is a result of Agilent's Academia Programme, which facilitates collaborations with universities around the world.
The programme assists universities with teaching, materials and creating research partnerships.
